Piper Sandler Maintains Overweight on Helmerich & Payne, Raises Price Target to $41

Benzinga Newsdesk www.benzinga.com Positive 57.7%

Neg 0% Neu 0% Pos 57.7%

Piper Sandler analyst Derek Podhaizer maintains Helmerich & Payne (NYSE:HP) with a Overweight and raises the price target from $40 to $41.